22.03.2013 Views

Phenobarbital and its Sodium Salt - IARC Monographs on the ...

Phenobarbital and its Sodium Salt - IARC Monographs on the ...

Phenobarbital and its Sodium Salt - IARC Monographs on the ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Table 2 (c<strong>on</strong>td)<br />

Country (reference) Subjects Exposure estimates Odds ratio (95% CI) Comments<br />

Childhood neuroblastoma<br />

USA<br />

(Kramer et al., 1987)<br />

Lung cancer<br />

Denmark<br />

(Olsen et al., 1993)<br />

Bladder cancer<br />

Denmark<br />

(Olsen et al., 1993)<br />

Primary liver cancer<br />

Denmark<br />

(Olsen et al., 1995)<br />

104 patients<br />

104 c<strong>on</strong>trols<br />

104 patients<br />

200 c<strong>on</strong>trols<br />

18 patients<br />

33 c<strong>on</strong>trols<br />

26 patients<br />

49 c<strong>on</strong>trols<br />

Mo<strong>the</strong>rs’ phenobarbital<br />

use<br />

Neurally active drugs<br />

<str<strong>on</strong>g>Phenobarbital</str<strong>on</strong>g> treatment<br />

Ever versus never<br />

1–749 g<br />

≥ 750 g<br />

<str<strong>on</strong>g>Phenobarbital</str<strong>on</strong>g> treatment<br />

Ever versus never<br />

1–749 g<br />

≥ 750 g<br />

<str<strong>on</strong>g>Phenobarbital</str<strong>on</strong>g> treatment<br />

Ever versus never<br />

5–749 g<br />

≥ 750 g<br />

[2.9%]<br />

[0.0%]<br />

2.8 (1.3–6.0)<br />

1.2<br />

1.6<br />

1.0<br />

0.3<br />

0.6<br />

0.2<br />

2.0<br />

0.4<br />

3.2<br />

(0.7–2.2)<br />

(0.8–3.0)<br />

(0.5–1.8)<br />

(0.1–0.9)<br />

(0.1–2.7)<br />

(0.0–0.9)<br />

(0.5–7.2)<br />

(0.1–3.4)<br />

(0.7–14)<br />

Formal risk estimates<br />

were not provided.<br />

90% CI<br />

176<br />

<str<strong>on</strong>g>IARC</str<strong>on</strong>g> MONOGRAPHS VOLUME 79

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!